Concepedia
Publication | Closed Access
Ruxolitinib for the treatment of inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): a randomised, open-label, phase 3b study
245
Citations
26
References
2016
Year
Polycythaemia VeraMedicinePharmacologyHematologyOncology
Page 1